Abstract: Development of micro-and nanotechnology for the study of living cells, especially in the field of drug delivery, has gained interest in recent years. Although several studies have reported successful results in the internalization of micro-and nanoparticles in phagocytic cells, when nonphagocytic cells are used, the low internalization efficiency represents a limitation that needs to be overcome. It has been reported that covalent surface modification of micro-and nanoparticles increases their internalization rate. However, this surface modification represents an obstacle for their use as drug-delivery carriers. For this reason, the aim of the present study was to increase the capability for microparticle internalization of HeLa cells through the use of noncovalently bound transfection reagents: polyethyleneimine (PEI) Lipofectamine™ 2000 and FuGENE 6 ® . Both confocal microscopy and flow cytometry techniques allowed us to precisely quantify the efficiency of microparticle internalization by HeLa cells, yielding similar results. In addition, intracellular location of microparticles was analyzed through transmission electron microscopy and confocal microscopy procedures. Our results showed that free PEI at a concentration of 0.05 mM significantly increased microparticle uptake by cells, with a low cytotoxic effect. As determined by transmission electron and confocal microscopy analyses, microparticles were engulfed by plasma-membrane projections during internalization, and 24 hours later they were trapped in a lysosomal compartment. These results show the potential use of noncovalently conjugated PEI in microparticle internalization assays.
Introduction
In the past decade, the fabrication of microelectromechanical systems with controlled physical and chemical properties in the micron and submicron scales has been of great interest in the biomedical field due to the high number of potential applications that they offer, such as the creation of biosensor systems, drug delivery systems, or therapeutic implants. 1 In fact, fabrication of biological microelectromechanical systems for a wide range of applications, such as cell tracking, 2 embryo tagging 3 or drug delivery, [4] [5] [6] has been achieved. The application of biological microelectromechanical systems has acquired special importance due to their potential use in creating systems able to deliver a drug, in a controlled manner, to a specific target cell. 7 The aforementioned studies have been successful with use of phagocytic cells, but when nonphagocytic cells are used, their low capacity of internalization is still a limitation that has to be overcome. Moreover, it has been shown that several features of microparticle design play an important role in their uptake by cells: their size, 8, 9 shape, 10, 11 and surface properties. 12 Several molecules have been used to increase the capacity for microparticle uptake in nonphagocytic cells, in order to study the internalization process. In all cases, the microparticles were covalently modified with a selected molecule [13] [14] [15] or coated with a bacterial membrane. 16 Since it has been reported that positive-charged microparticles are more easily internalized by cells, 11 the use of transfection procedures in microparticle internalization experiments could be considered as a possible approach to increase microparticle uptake when working with nonphagocytic cells. These procedures are based on the interaction between the positive charges of cationic polymers, like polyethyleneimine (PEI) or cationic lipids, like Lipofectamine TM 2000 (LF2000), FuGENE ® , or DOTAP, and the negative charges of DNA. 17 The positive charges of the transfection reagents can also interact with the negatively charged oligosaccharides of the plasma membrane surface, facilitating the internalization of the complex by endocytosis. Once inside the cell, these reagents can disrupt the endocytic pathway, releasing the contents of the endosomes to the cytosol. 18, 19 In fact, the covalent binding of PEI to the microparticle surface facilitates their incorporation into HeLa cells. 14, 20 However, the modification of microparticles with covalently bound PEI would render difficult or even impede their functionalization with other molecules, such as the drug to be delivered. Thus, a new strategy is necessary to improve microparticle uptake by nonphagocytic cells. In this sense, cationic lipids have been recently used as fusogenic agents to improve the internalization of polystyrene particles. 21 Against this background, the aim of this study was to improve the efficiency of internalization of polystyrene microparticles by nonphagocytic (HeLa) cells through the use of the cationic polymer PEI and the cationic lipids LF2000 and FuGENE 6 added to the culture medium as transfection agents. The internalization efficiency was evaluated using two completely different methods, confocal scanning laser microscopy (CSLM) and flow cytometry (FC), and took into account first, the cytotoxic effect of the transfection agent at one (LF2000) or three different concentrations (PEI), and second, the number of live, adhered cells with an internalized microparticle. Finally, the intracellular fate of microparticles was determined by immunogold labeling transmission electron microscopy (TEM) and by CSLM.
Materials and methods Reagents
Unless otherwise stated, reagents were purchased from Life Technologies (Carlsbad, CA). 
Polystyrene microparticles

Cell culture
HeLa cells were cultured at 37°C in a 5% CO 2 atmosphere, using minimum essential medium (MEM) with Earle's salts and L-Glutamine supplemented with 10% fetal bovine serum (FBS).
PEI, LF2000, and FuGENE 6 cytotoxicity assay
The cytotoxicity of PEI 25 KDa (Sigma-Aldrich, St Louis, MO) used at three different concentrations (0.05, 0.10, and 0.15 mM), of LF2000 (Life Technologies), and of FuGENE 6 (Promega Corporation, Fitchburg, WI), used at the concentrations recommended by the manufacturers, was evaluated after the transfection procedure by assessing two different parameters: the percentage of cells that remained attached to the dish (normalized to the control group), and the viability of the attached cells. The global effect of the treatment was calculated by multiplying the normalized percentage of attached cells by the percentage of viable attached cells.
For the first parameter tested, ie, the percentage of cells that remained attached after the transfection procedure, 1.5 × 10 5 HeLa cells were seeded in 35 mm diameter dishes (Nalge Nunc Int, Roskilde, Denmark). The next day, the transfection reagents at their respective concentrations were prepared and added to the cell cultures. Briefly, PEI 10 mM was initially diluted with NaCl 150 mM, incubated at room temperature for 40 minutes, and then diluted to the three working concentrations (0.05, 0.10, and 0.15 mM) in MEM without serum. LF2000 and FuGENE 6 were prepared according to the manufacturer's instructions, also in MEM without serum. The culture medium of HeLa cells was then replaced with the corresponding transfection solution, and the cells were incubated for 4 hours at 37°C and 5% CO 2 . After that, the transfection solutions were replaced with fresh culture medium. In the control culture, a 4-hour incubation with MEM without serum was performed. To determine the submit your manuscript | www.dovepress.com Dovepress Dovepress number of cells that remained attached, cells were harvested 24 hours later using 0.05% Trypsin-EDTA, centrifuged at 500 g for 5 minutes, and resuspended in fresh culture medium. Then, 50 µL of cell suspension was mixed with 50 µL of Perfect-Count Microspheres™ CYT-PCM50 (Cytognos SL, Salamanca, Spain) and counted in a Becton Dickinson FACSCanto II flow cytometer (BD Biosciences, Franklin Lakes, NJ) equipped with BD Biosciences FACSDiva™ software, the beads and the cells being counted together. The cell concentration was obtained taking into account the concentration of Perfect-Count microspheres.
On the other hand, to evaluate cell viability after the transfection procedures, cells were seeded and incubated with the transfection reagents, at the indicated concentrations. At 24 hours, attached cells were harvested as described, and their viability was determined by FC after applying the LIVE/DEAD ® Viability/ Cytotoxicity Kit for mammalian cells (L3224; Life Technologies), according to the manufacturer's instructions. The calcein acetomethoxy (AM) derivative of the kit diffuses through the cell membrane and, once inside the cell, it is converted to highly green fluorescent calcein by the intracellular esterases of living cells. The ethidium homodimer-1 of the kit can only enter cells with damaged membranes, being able to reach the nucleus and bind to DNA, which emits red fluorescence. Therefore, living cells are labeled with green fluorescence, whereas dead cells are labeled with red fluorescence.
Analysis of Zeta potential of polystyrene microparticles
The Zeta potential of microparticles in culture media before and after PEI, LF2000, and FuGENE 6 treatments, was measured using a Zetasizer Nano ZS (Malvern Instruments Malvern, UK).
Internalization of polystyrene microparticles in HeLa cells
To analyze the internalization of microparticles in HeLa cells, two approaches were carried out: CSLM (Fluoview ® FV1000; Olympus Corp, Tokyo, Japan) and FC (previously described). For confocal microscope analysis, cells were seeded at a density of 1.5 × 10 5 cells/dish on 35 mm-diameter gridded glass-bottom coverslip dishes (MatTek Corp, Ashland, MA). For FC analysis, cells were seeded at a density of 1.2 × 10 6 cells/flask on 75 cm 2 flasks (Nunc). After 24 hours of incubation, transfection was performed as described in the previous section. But, in this case, transfection solutions were mixed with 3 µm diameter polystyrene fluorescent microparticles at a final concentration of 10 6 microspheres/mL. The efficiency of internalization of microparticles by HeLa cells was determined 24 hours later. For FC analyses, cells were harvested as mentioned above and microparticle-cell association was analyzed measuring the forward scatter and the fluorescent intensity.
For CSLM analyses, cells were washed twice with phosphate-buffered saline (PBS) for 5 minutes, and fixed with 4% paraformaldehyde (Sigma-Aldrich). Then, cells were washed thrice with PBS, blocked with 1% bovine serum albumin ([BSA] Sigma-Aldrich) in PBS, and finally stored at 4°C until their analysis. Samples were first examined under a phase contrast inverted microscope (Olympus IX71, Olympus, Hamburg, Germany) to determine the percentage of cells that were in contact with one or more microparticles. Thus, several fields were captured and then analyzed using image analysis software (ImageJ version 1.43r; National Institutes of Health, Bethesda, MD). Two hundred cells per sample were evaluated for each treatment, and 484 cells in the case of the control group. Following this preliminary assessment, the location of microparticles (ie, inside the cells or attached to their plasma membrane) was determined using CSLM. With this aim, cells were stained with wheat germ agglutinin conjugated to Texas Red (10 µg/mL; Life Technologies) and counterstained with Hoescht 33258 (1 µg/mL; Sigma-Aldrich), to visualize the plasma membrane and the nucleus, respectively. Samples were then examined under the CSLM using a 63 × oil immersion objective, where x-y-z sequential acquisition was performed and orthogonal projections of the stacks were analyzed to determine the location of the microparticles within the cell. For the image analyses, the FV10-ASW Application Software (Ver. 01.07c; Olympus) was used.
The use of gridded dishes allowed us to examine the same fields in both microscopic evaluations (ie, inverted microscope and CSLM).
Electron microscopy
To analyze the intracellular location of microparticles, transfected cells (as described in above) were fixed with 2.5% glutaraldehyde in phosphate buffer (PB). After 1 hour of incubation with the fixative at 4°C, they were washed with PB and postfixed with 1% osmium tetroxide in PB containing 0.8% potassium ferricyanide at 4°C. Next, samples were dehydrated in acetone, infiltrated with Epon™ (Electron Microscopy Sciences, Hatfield, PA) resin over 2 days, embedded in the same resin, and polymerized at 60°C over 48 hours. Ultrathin sections were obtained using a Leica Ultracut UC6 ultramicrotome (Leica Microsystems, Wetzlar, Germany) and mounted submit your manuscript | www.dovepress.com
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on Formvar-coated copper grids. They were stained with 2% uranyl acetate in water and lead citrate. Finally, sections were observed in an electron microscope (J1010; Jeol Ltd, Tokyo, Japan) equipped with a CCD camera SIS Megaview III.
Lysosome associated membrane protein 1 (LAMP-1) immunogold
After microparticle internalization using PEI 0.05 mM treatment, HeLa cells were chemically fixed at 4°C with a mixture of 4% paraformaldehyde and 0.1% glutaraldehyde in PB. After washing with PB containing 50 mM glycine, cells were embedded in 12% gelatine and infused in 2.3 M sucrose. Mounted gelatine blocks were frozen in liquid nitrogen. Thin sections were prepared in an EM Ultracut UC6/FC6 ultracryomicrotome (Leica Microsystems, Wetzlar, Germany). Ultrathin cryosections were collected with 2% methylcellulose in 2.3 M sucrose.
Cryosections were incubated at room temperature on drops of 2% gelatine in PBS for 20 minutes at 37°C, followed by 50 mM glycine in PBS for 15 minutes, 10% FBS in PBS for 10 minutes, and 5% FBS in PBS for 5 minutes. Then they were incubated with 5 µL of rabbit anti-LAMP-1 polyclonal antibody (Abcam, Cambridge, UK) for 30 minutes. After three washes on drops of PBS for 10 minutes, sections were incubated for 20 minutes using colloidal gold conjugated goat anti-rabbit IgG (cat. 111-205-144) Jackson Immunoresearch Laboratories Inc, West Grove, PA) using a 1:30 dilution in 5% FBS/PBS. This was followed by three washes on drops of PBS for 10 minutes, and two washes with distilled water. As a control for nonspecific binding of the colloidal gold conjugated antibody, the primary antibody was omitted.
The observations were done in an electron microscope (Jeol) with a CCD camera SIS Megaview III.
Early endosome antigen 1 protein (EEA-1) and LAMP-1 immunolabeling
To visualize the location of the microparticles 24 hours after the transfection procedure, cells were seeded at a density of 1.5 × 10 5 cells/dish on 35 mm-diameter gridded glass-bottom coverslip dishes (MatTek Corp). After 24 hours of incubation, transfection with PEI 0.05 M mixed with 3 µm diameter polystyrene functionalized microparticles (previously described) at a final concentration of 10 6 microspheres/mL was performed as described above. After 24 hours, cells were washed twice with PBS fixed in 4% paraformaldehyde/PBS, permeabilized with 0.25% Triton X-100 in PBS, and blocked with 5% PBS/BSA. Then, cells were incubated for 1 hour at 37°C with one of two primary antibodies, mouse anti-EEA-1 monoclonal antibody (cat. 610456 BD Biosciences) or mouse anti-LAMP-1 polyclonal antibody (cat. 555798 BD Biosciences), to label the endosomal or the lysosomal compartment, respectively. Finally, cells were incubated for 1 hour at room temperature with Alexa 488-conjugated chicken anti-mouse IgG antibody (Life Technologies), counterstained with Hoescht 33258, and analyzed by CSLM. For each marker, 40 cells with microparticles were analyzed.
Statistical analyses
Normal distribution of data was verif ied with the Kolmogorov-Smirnov test, and homoscedasticity was assessed with the Levene's test. When necessary, data (x) on percentages were transformed with arcsin square root transformation (arcsin√x) for accomplishing the parametric assumptions. The comparison among the different treatments was done with a one-way analysis of variance (ANOVA), followed by a posthoc t-test with Bonferroni's correction for multiple comparisons. P , 0.05 was considered to be statistically significant.
Results
Cytotoxic effect of transfection reagents
The percentage of cells that remained attached to the dish after the transfection procedures can be seen in Figure 1A , showing that all treatments resulted in a significant decrease in the percentage of attached cells. Normalized to the control group, PEI 0.05 mM was the less aggressive treatment (77.4% of cells remaining attached) when compared with the rest of the treatments (47.5%, 36.5%, 20.8%, and 20.1% for PEI 0.10 mM, FuGENE 6, LF2000, and PEI 0.15 mM, respectively).
The viability of the attached cells was determined by calcein AM/ethidium homodimer-1staining. Figure 1B shows that after PEI 0.10 mM and 0.15 mM treatments, the percentages of living cells were significantly lower (65.6% and 62.5%, respectively) than those observed following the other treatments (94.7% [control], 94.1% [FuGENE 6], 90.4% [PEI 0.05 mM], and 87.6% [LF2000]). Moreover, the difference between control and LF2000 was also significant.
When both parameters are considered ( Figure 1C ), PEI 0.05 mM appears as the least cytotoxic treatment, with 70% of cells remaining viable; whereas in the other treatments, less than 35% of the cells remained alive (34.3% FuGENE 6; 31.2% PEI 0.10 mM; 12.6% PEI 0.15 mM; and 18.2% LF2000).
Effect of transfection reagents on microparticle surface charge
To evaluate the electrochemical changes at the microparticle surface due to the treatment with the transfection reagents, their Z potential was analyzed. As can be seen in Figure 2 , nontreated fluorescent microparticles showed a highly negative Z potential (-45.9), whereas treatment with the transfection reagents clearly changed the surface to positively charged. This change also occurred in functionalized microparticles after PEI 0.05 treatment.
Internalization of polystyrene microparticles by HeLa cells
Microparticle internalization by HeLa cells was evaluated by two approaches, FC and CSLM. By FC, it was observed that for all treatments, the number of cells in contact with microparticles was clearly increased from twofold (PEI 0.15 mM) to fivefold (PEI 0.05 mM) when compared with the control (Figure 3 ). In addition, for all treatments, in the population of cells associated with microparticles, there were no differences among the percentages of cells with one, two, three, or more microparticles (Figure 4 ). Confocal microscopy analyses were performed next to precisely determine whether microparticles were located inside or outside the cells (Figure 5A and B) . As can be seen in Figure 5C Finally, the results obtained from FC and CSLM analyses were compared taking into account the cytotoxic effect of the different treatments (see Figure 1C) . Figure 6 shows that PEI 0.05 mM provided the highest microparticle internalization efficiency, doubling at least the efficiency of the other treatments.
Internalization of functionalized polystyrene microparticles by HeLa cells
To test whether PEI 0.05 mM could also enhance microparticle internalization when a cargo is covalently attached to their surface, the internalization efficiency of antibodyfunctionalized microparticles was determined by CSLM. This analysis showed that 18.9% of the cells had internalized at least one functionalized microparticle, a percentage equivalent to that for non-functionalized microparticles (25.5%) and significantly higher than that for the control group (3.7%).
Intracellular location of microparticles
To investigate the intracellular fate of microparticles, TEM analyses were carried out in Epon-embedded samples. According to the previous results, only the PEI 0.05 mM treatment was selected for these analyses. A plasma membrane evagination was clearly observed around microparticles whilst they were being engulfed by HeLa cells ( Figure 7A by a single membrane in the majority of cases ( Figure 7B) , and occasionally, they were additionally surrounded by a two-membrane complex ( Figure 7C and D) .
The immunolocalization of LAMP-1 showed that in the majority of cells analyzed, the membrane surrounding the microparticles was positive for LAMP-1, indicating that microparticles were trapped in a lysosomal compartment (Figure 8 ).
To quantify the number of internalized microparticles located inside lysosomes, CSLM analysis using two cell compartment markers (EEA-1 for endosomes and LAMP-1 for lysosomes) was carried out. In this case, antibodyfunctionalized microparticles were used because their lower fluorescence intensity in relation to fluorescent microparticles allowed us to observe the colocalization of the internalized microparticles and the endosomal/lysosomal compartments. It was observed that 24 hours after treatment, none of the microparticles colocalized with endosomes and 83.4% colocalized with lysosomes, confirming the results previously obtained by TEM.
Discussion
The use of micro-and nanoparticles as carriers for drug delivery applications has gained interest in recent years. 7 It has been shown that their uptake by cells is highly dependent on their physical and chemical properties, especially their size and surface charge (being that cationic particles are more easily uptaken by cells). 11 However, the low capacity of nonphagocytic cells for the internalization of micron-sized particles is a handicap that needs to be improved.
In order to increase microparticle uptake by nonphagocytic cells, PEI, LF2000, and FuGENE 6 were chosen because of their efficiency in DNA transfection procedures. Moreover, PEI and LF2000 have also been used in microparticle- 14, 20, 21 and nanoparticle-internalization 22 experiments. In our study, we analyzed the effect of free PEI (ie, noncovalently bound to microparticle surface) on the microparticle-internalization efficiency. Considering that these microparticles are expected to be drug-delivery carriers in the future and that the cargo will need to be attached to their surface, we considered the use of free PEI as a more appropriate approach to avoid competition for the same substrate. To the best of our knowledge, this is the first time that free PEI has been used for internalizing microparticles. In this regard, although PEI, LF2000, and FuGENE 6 have been widely used in DNA transfection procedures with positive results, it has been described that they produce a considerable cytotoxic effect, which has to be taken into account. 18, 23 Thus, with the aim of finding the best balance between efficiency of microparticle internalization and cytotoxicity, three different concentrations of PEI were tested in the present study. The highest concentration was set at 0.15 mM since it has been reported that an intense cytotoxic effect is observed at higher concentrations. 24 In the case of LF2000 and FuGENE 6, the concentrations used were those recommended by the manufacturers, which provided good results when used for internalizing 1 or 3 µm-sized beads in the case of LF2000. 21 In our study, the number of cells remaining attached to the culture plates after their exposure to the transfection reagents was determined, together with the viability of these attached cells. This combined analysis allowed us to more accurately determine the cytotoxic effect of the treatments. We observed that compared with the control culture, the percentage of viable cells among those attached was high in all treatments (more than 60% viable cells), but a reduction in the percentage of attached cells was observed for all treatments. These data demonstrate the usefulness of taking into account not only the viability of the cells but also the percentage of remaining cells after treatments in the cytotoxicity assays and moreover, showed that PEI at 0.05 mM was the least cytotoxic treatment. On the other hand, our viability results are in agreement with previous reports in that free PEI treatments produced a dose-dependent cytotoxic effect. 25 None of the submit your manuscript | www.dovepress.com
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reported studies that used LF2000 to improve microparticle uptake 21, 26 analyzed the cytotoxic effect of this agent. To calculate the efficiency of microparticle uptake, two different strategies were used. FC studies allowed us to clearly identify the population of cells associated with microparticles but also to discriminate among cells associated with one or more microparticles. The results obtained by FC showed that all treatments increased the percentage of cells associated with microparticles, especially PEI 0.05 mM (25.9%) and LF2000 (20.4%). Furthermore, no significant differences were found between these two treatments, indicating that both would be equally efficient in terms of microparticle internalization. In the case of PEI, a decrease in the percentage of cells in contact with microparticles was observed as PEI concentration was increased. However, FC did not allow us to distinguish between internalized microparticles and those only bound to the cell surface.
To complement the FC data and to determine the location of microparticles, confocal analyses of cells were performed. By confocal microscopy, it was possible to discriminate and quantify the number of microparticles that had been internalized or that were only in contact with the cell surface. With regards to the use of LF2000, our results are in agreement with those of Kobayashi et al, 21 who reported an increase in the rate of internalization of 1 µm-sized microparticles by HeLa cells when using this reagent. On the other hand, and concerning the use of PEI, the data obtained in the present study agree with previous studies, such as that of Thiele et al, 14 who demonstrated that microparticles covalently bound to PEI are more efficiently internalized by macrophages and dendritic cells than are microparticles alone. In the present study, we demonstrated that PEI could also increase microparticle internalization in nonphagocytic cells, and that this could be accomplished without its covalent attachment to the microparticle surface. In addition, we observed a dose-dependent, inverse relationship between PEI concentration and internalization efficiency. In agreement with FC, quantification by CSLM indicated that increasing concentrations of PEI not only resulted in an increase in the number of microparticles in contact with cells, but also in a decreased internalization. Our results suggest that the lower internalization rates at higher PEI concentrations could be related to its higher cytotoxic effect, especially membrane damage, 27, 28 which would lead to an incapability of the affected cells for microparticle internalization.
The higher efficiency of microparticle internalization after their treatment with a transfection reagent seems to be related to the changes in surface charges, as determined by the results of the Z potential analysis. Our results also showed that although surface properties of the microparticles were modified after the antibody conjugation, PEI could still interact with them, increasing their uptake by cells without affecting the fluorescence emission of the functionalizing molecule.
Both FC and CSLM analyses showed that, when the cytotoxic effect of the transfection reagents is considered, PEI 0.05 mM turns out to have been the most effective treatment, since it led to at least a twofold increased microparticle internalization rate. The advantage of FC was the high number of cells that could be analyzed in a short period of time, whereas the advantage of CSLM was its ability to ascertain internalization.
Considering that microparticles are expected to deliver their cargo inside the cell, it is necessary to determine their exact location inside the cell. Our results, using TEM analyses, showed that they were engulfed by a cell membrane submit your manuscript | www.dovepress.com Dovepress Dovepress evagination and no discernible coat was visible. We also observed that once inside the cell, they appeared to be tightly surrounded by a single membrane, positive for the LAMP-1 lysosome marker, indicating that after 24 hours, the majority of microparticles were entrapped in lysosomes. These results have been confirmed by the use of nonfluorescent microparticles functionalized with an Alexa 594-conjugated secondary antibody, as the majority of internalized microparticles were also localized in the lysosomal compartment. We anticipated that using PEI, microparticles would be found in the cytosol, because it has been previously reported that the capability of protonation of PEI results in the disruption of endosomes. [29] [30] [31] Authors that have covalently attached PEI to microparticles 20 have reported that these particles can be found free in the cytosol as early as 4-6 hours posttransfection when using PEI 70 KDa but not when using PEI 25 KDa. Kobayashi et al 21 demonstrated that the use of free cationic lipids increases the internalization of microparticles and that once in the endosomes compartment, they escape in a few minutes. According to this author, the rupture of the endosome membrane induces the formation of an autophagosome. In our study by TEM, we found that a few microparticles were surrounded by a double membrane, which could correspond to endoplasmic reticulum, indicating that an autophagic process was taking place. Our results regarding the intracellular location of microparticles by CSLM confirmed the results of the TEM studies, indicating that in the majority (83.4%) of cells, the internalized microparticles were located in the lysosomal compartment. As no endosomal association with microparticles was observed, the microparticles that were not located in lysosomes could be either free in the cytosol, or part of an autophagic process. Further studies will be necessary to analyze whether, when microparticles are functionalized with a specific cargo, the cargo can be released into the cytosol even if the microparticle remains trapped inside an organelle.
Conclusion
To sum up, our results show that PEI 25 kDa at a concentration of 0.05 mM significantly increases microparticle internalization by nonphagocytic HeLa cells with a low cytotoxic effect, and that this can be achieved without the covalent binding of PEI to the microparticle surface. Both CSLM and FC can be used for the quantification of internalization efficiency, yielding similar results, but FC allows a fast analysis of high numbers of cells whereas CSLM allows distinction between cells with internalized microparticles and cells with microparticles attached to their surface. Finally, our results show that 0.05 mM PEI 25 kDa does not induce endosomal disruption, as internalized microparticles remain surrounded by a lysosomal membrane. With a view to drug delivery, further studies will be necessary to evaluate whether functionalized microparticles entrapped in lysosomes are still able to release their cargo into the cytosol.
